Europe’s main pharmaceutical regulator recommended suspending the sale of hundreds of drug formulations that were approved for use based on “flawed” clinical studies conducted by GVK Biosciences, a clinical research organization in Hyderabad, India.
via WSJ.com: US Business http://ift.tt/1CtPJju
via WSJ.com: US Business http://ift.tt/1CtPJju
Nessun commento:
Posta un commento